BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Brain and Central Nervous System Tumors|Breast Cancer|Cognitive/Functional Effects|Drug/Agent Toxicity by Tissue/Organ|Psychosocial Effects of Cancer and Its Treatment
Interventions: BIOLOGICAL: trastuzumab|DRUG: carboplatin|DRUG: methotrexate|DRUG: sodium thiosulfate
Sponsor: OHSU Knight Cancer Institute
Collaborators: National Cancer Institute (NCI)